In 376 PTCL patient samples, CD30 was expressed in 58% of PTCL-NOS, 63% of AITL, and almost 100% of ALCL. The gene discussed is TNFRSF8; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.